Breathtec Biomedical Inc Share Price Deutsche Boerse AG
Equities
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 2.6M 2.4M 205M |
---|---|---|---|---|---|
Net income 2022 | -6M -5.53M -472M | Net income 2023 | -6M -5.53M -472M | EV / Sales 2022 | - |
Net cash position 2022 | 1.41M 1.3M 111M | Net cash position 2023 | 125K 115K 9.85M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.55
x | P/E ratio 2023 |
-0.37
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.2% |
Managers | Title | Age | Since |
---|---|---|---|
Chris Moreau
CEO | Chief Executive Officer | 59 | 28/02/18 |
James Kinley
DFI | Director of Finance/CFO | 45 | 30/11/21 |
Chief Operating Officer | 41 | 28/02/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Harry Bloomfield
CHM | Chairman | 79 | 07/09/21 |
Chris Moreau
CEO | Chief Executive Officer | 59 | 28/02/18 |
Mark Williams
BRD | Director/Board Member | 52 | 21/09/21 |
1st Jan change | Capi. | |
---|---|---|
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |